Literature DB >> 11509609

Regulatory potential of fever-range whole body hyperthermia on Langerhans cells and lymphocytes in an antigen-dependent cellular immune response.

J R Ostberg1, C Gellin, R Patel, E A Repasky.   

Abstract

The febrile response is one of the most common features of infection and inflammation. However, temperature is rarely a variable in experimental immunological investigations. To determine whether the thermal microenvironment has any immunoregulatory potential in an Ag-dependent response, we applied a mild fever-range whole body hyperthermia (FR-WBH) protocol to BALB/c mice experiencing the contact hypersensitivity (CHS) reaction. We observed that the timing of this FR-WBH treatment relative to the different phases of the CHS response was crucial to the outcome. FR-WBH treatment before sensitization with a 0.5% FITC solution resulted in a depressed CHS response. This appears to be due to direct effects of FR-WBH on epidermal Langerhans cell trafficking to the draining lymph nodes. In contrast, application of FR-WBH directly after application of the elicitation dose of FITC solution resulted in an enhanced reaction. This result correlates with increased homing of lymphocytes to the site of elicitation. Overall, these data have important implications regarding the role of thermal changes experienced during infection and the clinical use of FR-WBH relative to immunotherapeutic strategies.

Entities:  

Mesh:

Year:  2001        PMID: 11509609     DOI: 10.4049/jimmunol.167.5.2666

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Regulation of a lymphocyte-endothelial-IL-6 trans-signaling axis by fever-range thermal stress: hot spot of immune surveillance.

Authors:  Trupti D Vardam; Lei Zhou; Michelle M Appenheimer; Qing Chen; Wang-Chao Wang; Heinz Baumann; Sharon S Evans
Journal:  Cytokine       Date:  2007-07       Impact factor: 3.861

Review 2.  Primary immune surveillance: some like it hot.

Authors:  Joseph J Skitzki; Qing Chen; W C Wang; Sharon S Evans
Journal:  J Mol Med (Berl)       Date:  2007-08-18       Impact factor: 4.599

3.  Differentiation of CD8+ T cells into effector cells is enhanced by physiological range hyperthermia.

Authors:  Thomas A Mace; Lingwen Zhong; Casey Kilpatrick; Evan Zynda; Chen-Ting Lee; Maegan Capitano; Hans Minderman; Elizabeth A Repasky
Journal:  J Leukoc Biol       Date:  2011-08-26       Impact factor: 4.962

Review 4.  Fever and the thermal regulation of immunity: the immune system feels the heat.

Authors:  Sharon S Evans; Elizabeth A Repasky; Daniel T Fisher
Journal:  Nat Rev Immunol       Date:  2015-05-15       Impact factor: 53.106

Review 5.  Hypoxia-driven immunosuppression: a new reason to use thermal therapy in the treatment of cancer?

Authors:  Chen-Ting Lee; Thomas Mace; Elizabeth A Repasky
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

6.  Immunological role of neuronal receptor vanilloid receptor 1 expressed on dendritic cells.

Authors:  Sreyashi Basu; Pramod Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-25       Impact factor: 11.205

Review 7.  Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function.

Authors:  Julie R Ostberg; Elizabeth A Repasky
Journal:  Cancer Immunol Immunother       Date:  2005-04-28       Impact factor: 6.968

Review 8.  Hyperthermia as an immunotherapy strategy for cancer.

Authors:  Joseph J Skitzki; Elizabeth A Repasky; Sharon S Evans
Journal:  Curr Opin Investig Drugs       Date:  2009-06

9.  Winner of the 2007 Society for Thermal Medicine Young Investigator Award. Fever-range whole body hyperthermia prevents the onset of type 1 diabetes in non-obese diabetic mice.

Authors:  Maegan L Capitano; Bradley R Ertel; Elizabeth A Repasky; Julie R Ostberg
Journal:  Int J Hyperthermia       Date:  2008-03       Impact factor: 3.914

Review 10.  Fine-tuning immune surveillance by fever-range thermal stress.

Authors:  Daniel T Fisher; Trupti D Vardam; Jason B Muhitch; Sharon S Evans
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.